The controversial molecular identification of (R)-2-methylheptyl isonicotinate (1) has been settled. Despite its significance as a potent anti-microbial agent against several clinically relevant pathogens, the structure of natural product is uncertain so far due to controversial reports. Its structure has been resolved as bis (2-ethylhexyl) phthalate (2) by total syntheses of chain isomers. In addition, we have also revised bis (2-methylheptyl) phthalate (3) as (2) in some reports.
Today, antibiotic resistance is a serious and complex global health problem that threatens to undermine the significant scientific and medical progress made so far in the development of new antibiotics to combat infectious diseases. This is mainly attributed to overuse or misuse of antibiotics. The genus Streptomyces is considered to be a rich source of novel antibiotics. In addition, many structures reported from this genus have been revised [1] [2] [3] . Some 16 years ago, the first report on the isolation of R-2-methylheptyl isonicotinate 1 (Figure 1 ), a new class of potent antimicrobial putative from the culture filtrates of Streptomyces sp. 201was published by Manob J. Bordoloi et al. [4] . Its structure was confirmed by spectroscopic data ( 1 H & 13 C NMR, IR, UV, MS) interpretation and elemental analysis. This compound is known to exhibit potent antimicrobial activity against dominant bacterial strains such as Bacillus subtilis, Escherichia coli, Shigella species, Klebsiella species, Proteus mirabilis as well as phytopathogens: Fusarium moniliforme, F. semitectum, F. solani, F. oxysporum, Rhizoctonia solani [5] [6] [7] . Its remarkable anti-microbial potential would be beneficial in the development of new antibiotics. Since then, its structure has attracted synthetic and biological community across the globe. Subsequently, Barua et al. were performed a total syntheses R and S isomers of 1 and established the absolute stereochemistry [8] . They also reported significant SAR studies on this compound against Mycobacterium tuberculosis H37rv. Although they claimed not only total syntheses of R and S isomers but also different analogues of compound 1 but failed to revise its structure.
Ten years later, it was also reported to be a metabolite of the tender shoots of Zanthoxylum oxyphyllum [9] . In 2015, Perlmutter and coworkers [10] confirmed the purported structure of this potent molecule by total syntheses of R and S isomers based on comparison of 1 H and 13 C NMR data of natural and synthetic compounds. They also reported contradictory in vitro antibacterial results against E. coli and Bacillus subtilis. Apart from these reports, no other contributions to its structure have been published so far and the structure remains uncertain so far. As part of our ongoing structural revision program [11] , we undertook a structural revision of this new class of putative by total synthesis. Herein, we report the structural revision of R-2-methylheptyl isonicotinate as bis (R-2-ethylheptyl) phthalate (2, BEHP) and corrected the 1 H & 13 C NMR data of bis (2-methylheptyl) phthalate (3, BMHP) as BEHP in few reports by total syntheses of chain isomers. Of special interest to revise the structure of novel antibiotic compound, we speculated that the actual structure of 1 was related to dialkyl phthalate ester series but not isonicotinate series as proposed by Bordoloi et al. A careful literature search on Streptomyces genus revealed the possibility of dialkyl phthalate ester. We undertook syntheses of chain isomers to verify the hypothesis. We believe that the present investigation is informative for researchers worldwide on the unambiguous structure of potent antimicrobial putative. We compared the reported 1 H & 13 C NMR data of compound 1 with those of chain isomers, BEHP (2) [12, 13] and BMHP (3) [14, 15] . To our surprise, the diagnostic signals of compound 1 were identical with those of 2 and 3 (see Tables S1 and  S2) , which indicated the structural revision of compounds 1 and 3. We presumed that their work ensures the occurrence of chain isomers, which is difficult to interpret without GC MS analysis. Moreover, Bordoloi's purported structure is probably due to the consideration of minor fragment ion at m/z 235 [M + -C 9 H 17 O 2 +H] as a molecular ion in its EIMS. Unfortunately Bordoloi et al. and Barua et al. could not compare the 1D NMR data with reported isonicotinates, which led to the wrong interpretation. Though spectroscopic differences between compounds 2 and 3 were anticipated to be small, and it was decided to synthesize both the isomers for comparison.
In view of the above observations, and also in order to exclude the possibility of bisalkyl phthalate ester to solve the unambiguous structure of compound 1, we prompted to synthesize chain isomers treatment with LiBH 4 . Chiral auxiliary is effective in controlling the stereoselectivity of the alcohols 9/10, which is identical with those of reported data [16, 17] . These alcohols were esterified with phthalic acid using EDC, 4-(N, N-dimethyl amino) pyridine in the presence of TEA to afford 2 and 3 in 74% yield with ee >99%.
Synthetic compound 2 exhibited 1, 2-disubstituted aromatic protons at δ (7.53, dd, J = 5.7, 3.3 Hz, 2H), (7.71, dd, J = 5.7, 3.3 Hz, 2H) similar to those of natural product 1 [(7.5, dd, J = 6, 4 Hz, 2H), (7.7, dd, J = 6, 4 Hz, 2H)]. In addition, 2 showed the characteristic phthalate ester signals at δ 167.7, 68.1 ppm identical to those of 1 [δ 168.09, 68.52 ppm]. As expected, the 1 H and 13 C NMR data of synthetic 2 were in accordance with those of natural product 1 except for the protons, 2′-H/2'′-H (δ 1.45, m). In addition, the authors neither provided the range of multiplet nor supplemental spectra to support this observation. However, 2′-H/2'′-H (δ 1.68, sept) of synthetic 2 were identical with those of BEHP (δ 1.66, m), which was previously reported from Pseudomonas [12] and Nocardia levis strains [13] .
Bisalkyl phthalates have been reported from a number of plants [18, 19] and microorganisms, especially Streptomyces mirabilis [20] NSQu-25, Pseudomonas [12] sp.PB01.These compounds are reported to possess antimicrobial and, cathepsin B inhibitory activities [12] . Perlmutter contradictory reports on E. coli and B. subtilis are due to the activity of isonicotinates while Bordoloi's results on BEHP. These results are corroborated with the isolation of BEHP from the same genus Streptomyces [21] , which showed potent antimicrobial activity on E. coli and B. subtilis reported by Mohammed H. EI-Sayed [20] with expected deviations in MIC values. It is noteworthy that studies directed towards the assignment of stereochemistry are required prior to explore bioefficacy of bisalkyl phthalates.
Experimental
General: All reagents and solvents were purchased from commercial grade suppliers and used as received. Optical rotations were determined on Perkin-Elmer polarimeter. IR spectra were recorded on a Nicolet-740 FT-IR spectrophotometer with KBr pellets. The NMR spectra were recorded with Bruker Avance 300/400/500 MHz for 1 H and 75/100/125 MHz for 13 C NMR spectra in CDCl 3 with TMS as internal standard. Coupling constants are given in Hz. The ESIMS data was recorded on an Agilent 1100 MSD with ESI SL Trap. The HR-ESIMS data were acquired on an Agilent 6510 Q-TOF and ESI probe. The chromatography was carried out using an Agilent HPLC system (1100 series, Waldbronn, Germany), consisting G1312A Binary Pump, G1379A Degasser, G1329A Autosampler and G1329B Thermostat. The separation of analyte was performed on OJ-H (250 mm x 4.6 mm i.d, 5 µm) at 274 nm using a mobile phase consisting of n-Hexane/IPA, mixed (80:20, v/v), pumped at a flow rate of 0.5 mL/min. The injection etc. should be detailed. A precise workup volume was 20 µL and the total analysis time per sample was 12 min at 27ºC.
Synthesis of (R)-4-Benzyl-3-hexanoyl oxazolidin-2-one (5):
A solution of 4 (0.5 g, 2.82 mmol) in THF (10 mL) was cooled to -78°C and n-butyl lithium 1.54 M solution in n-hexane (1.83 mL, 2.82 mmol) was added drop wise and the reaction mixture was allowed to stir for 30 min. n-Hexanoyl chloride (0.39 mL, 2.82 mmol) was added and stirred for another 30 min at the same temperature. The reaction mixture was quenched with saturated aqueous NaHCO 3 and extracted with ethyl acetate (15 mL x 2), washed with 10% citric acid, brine, dried over MgSO 4 , filtered and evaporated in vacuo. The crude residue was purified by column chromatography on silica gel (n-hexane/ EtOAc =19:1) to afford (R)-4-benzyl-3-hexanoyl oxazolidin-2-one (5) in 94% yield (730 mg) as sticky oil, which will solidify after long standing; R ƒ =0.58 (n-hexane/ EtOAc=8:2).
[α] 
Synthesis of (R)-4-Benzyl-3-((R)-2-ethylhexanoyl) oxazolidin-2-one (7):
To a stirred solution of (R)-4-benzyl-3-hexanoyloxaz olidin-2-one (5) (300 mg, 1.09 mmol) in THF (15 mL) was added slowly a solution of NaHMDS (1.0 M in THF) (1.09 mL, 1.09 mmol) at -78 °C. After stirring the reaction mixture at the same temperature for 1 h, ethyl iodide (340 mg, 2.18 mmol) was added drop wise. The resulting mixture was allowed to stir at -78 °C for 2 h. The reaction was quenched with saturated solution of ammonium chloride at -30°C. The aqueous phase was extracted with CHCl 3 (2 x 25 mL), the organic extracts were dried over Na 2 SO 4 and the solvent was removed under vacuo. The residue was purified by column chromatography on silica gel (n-hexane/ EtOAc= 95 : 5) to afford the compound 7 as a colorless oil in 89% yield (294 mg); R ƒ =0.72 (n-hexane/ EtOAc=8:2). 
Synthesis of (R)-2-Ethylhexanol (9):
To a solution of (R)-4-benzyl-3-((R)-2-ethyl hexanoyl) oxazolidin-2-one (7) (200 mg, 0.66 mmol) in dry Et 2 O (5 mL), ethanol (33 mg, 0.71 mmol) was added and lithium borohydride (17 mg, 0.82 mmol) was added slowly at 0°C. The reaction mixture was stirred at the same temperature for 1 h and quenched with water (10 mL), extracted with ether (2 x 15 mL), washed with brine (2 x 10 mL), dried over Na 2 SO 4 and the solvent was removed under reduced pressure. The crude product was purified by column chromatography on silica gel (pentane /Et 2 O =9:1) to afford 9 as a colorless oil in 90% yield (77 mg); R ƒ =0.52 (n-hexane/ Et 2 O=7:3).
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Synthesis of Bis ((R)-2-Ethylhexyl) Pthalate (2):
To phthalic acid (45 mg, 0.27 mmol), EDC.HCl (155 mg, 0.81 mmol), Et 3 N (0.11 mL, 0.81 mmol), and a catalytic amount of 4-(N, N-dimethyl amino) pyridine was added successively. To this a solution of the alcohol (9) (70 mg, 0.54 mmol) in DCM was added and the reaction mixture was stirred for 16 h at rt. The reaction mixture was quenched with cold water and extracted with EtOAc (3 x 10 mL). The combined organic layers were washed with water, brine (2 x10 mL), dried over Na 2 SO 4 and evaporated. The crude residue was purified by silica gel column chromatography (n-hexane/ EtOAc = 9.7:0.3) to afford 2 as pale yellow oil in 74% yield (78 mg); Rƒ=0.54 (n-hexane/ EtOAc=9:1) The enantiomeric excess was determined by chiral HPLC for the compound (2) ee : 99%.
Synthesis of (R)-4-Benzyl-3-heptanoyloxazolidin-2-one (6):
Following the procedure adopted for compound 5, acylation of (R)-4-benzyl oxazolidin-2-one 4 (500 mg, 2.82 mmol) gave a crude mixture, which on purification by silica gel column chromatography afforded (R)-4-benzyl-3-heptanoyloxazolidin-2-one as a sticky oil, in 94% yield (767 mg) which will solidify after long standing; R ƒ =0.58 (n-hexane/ EtOAc=8:2). 
Synthesis of (R)-4-Benzyl-3-((R)-2 Methylheptanoyl) oxazolidin-2-one (8):
To a stirred solution of (R)-4-benzyl-3-heptanoyloxazol idin-2-one (6) (300 mg, 1.03 mmol) in THF (15 mL) was added slowly a solution of NaHMDS (1.0 M in THF) (1.03 mL, 1.03 mmol) at -78 °C. After stirring the reaction mixture was kept at the same temperature for 1 h, methyl iodide (181 mg, 2.06 mmol) was added drop wise. The resulting mixture was allowed to stir at -78 °C for 2 h. The reaction was quenched with saturated solution of ammonium chloride at -30 °C. The aqueous phase was extracted with CHCl 3 (2 x 25 mL), the organic extracts were dried over Na 2 SO 4 and the solvent was removed under vacuo. The residue was purified by column chromatography on silica gel (n-hexane/ EtOAc= 95: 5) to afford the compound 8 as a colorless oil in 75% yield (235 mg); R ƒ =0.66 (n-hexane/ EtOAc=8:2 
Synthesis of Bis (R-2-Methylheptyl) phthalate (3) :
Following the same procedure adopted for compound 2, esterification of phthalic acid (45 mg, 0.27 mmol) with alcohol 10 gave a crude mixture, which on purification by silica gel column chromatography to afford the compound 3 as a pale yellow oil in 74% yield (78 mg), The enantiomeric excess was determined by chiral HPLC for the compound (3) ee : 99%; R ƒ =0.56 (n-hexane/ EtOAc=9:1).
[α] Tables S1, S2 and spectral data of all compounds are available.
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